000 01375 a2200409 4500
005 20250513024828.0
264 0 _c19810324
008 198103s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/1097-0142(19801215)46:12<2682::aid-cncr2820461224>3.0.co;2-t
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGarofalo, J A
245 0 0 _aSerum zinc, copper, and the Cu/Zn ratio in patients with benign and malignant breast lesions.
_h[electronic resource]
260 _bCancer
_cDec 1980
300 _a2682-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdenocarcinoma
_xmetabolism
650 0 4 _aAdult
650 0 4 _aAge Factors
650 0 4 _aAged
650 0 4 _aBreast Neoplasms
_xmetabolism
650 0 4 _aCopper
_xblood
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPrognosis
650 0 4 _aZinc
_xblood
700 1 _aAshikari, H
700 1 _aLesser, M L
700 1 _aMenendez-Botet, C
700 1 _aCunningham-Rundles, S
700 1 _aSchwartz, M K
700 1 _aGood, R A
773 0 _tCancer
_gvol. 46
_gno. 12
_gp. 2682-5
856 4 0 _uhttps://doi.org/10.1002/1097-0142(19801215)46:12<2682::aid-cncr2820461224>3.0.co;2-t
_zAvailable from publisher's website
999 _c7448199
_d7448199